CoChat

Increasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States

Open access

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The emergence of drug-resistant strains of bacteria has complicated treatment decisions and may lead to treatment failures. METHODS: We examined data on invasive pneumococcal disease in patients identified from 1995 to 1998 in the Active Bacterial Core Surveillance program of the Centers for Disease Control and Prevention. Pneumococci that had a high level of resistance or had intermediate resistance according to the definitions of the National Committee for Clinical Laboratory Standards were defined as "resistant" for this analysis. RESULTS: During 1998, 4013 cases of invasive Streptococcus pneumoniae disease were reported (23 cases per 100,000 population); isolates were available for 3475 (87 percent). Overall, 24 percent of isolates from 1998 were resistant to penicillin. The proportion of isolates that were resistant to penicillin was highest in Georgia (33 percent) and Tennessee (35 percent), in children under five years of age (32 percent, vs. 21 percent for persons five or more years of age), and in whites (26 percent, vs. 22 percent for blacks). Penicillin-resistant isolates were more likely than susceptible isolates to have a high level of resistance to other antimicrobial agents. Serotypes included in the 7-valent conjugate and 23-valent pneumococcal polysaccharide vaccines accounted for 78 percent and 88 percent of penicillin-resistant strains, respectively. Between 1995 and 1998 (during which period 12,045 isolates were collected), the proportion of isolates that were resistant to three or more classes of drugs increased from 9 percent to 14 percent; there also were increases in the proportions of isolates that were resistant to penicillin (from 21 percent to 25 percent), cefotaxime (from 10 percent to 15 percent), meropenem (from 10 percent to 16 percent), erythromycin (from 11 percent to 16 percent), and trimethoprim-sulfamethoxazole (from 25 percent to 29 percent). The increases in the frequency of resistance to other antimicrobial agents occurred exclusively among penicillin-resistant isolates. CONCLUSIONS: Multidrug-resistant pneumococci are common and are increasing. Because a limited number of serotypes account for most infections with drug-resistant strains, the new conjugate vaccines offer protection against most drug-resistant strains of S. pneumoniae.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm200012283432603

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Research works printed but not linked: 4

  1. Kramer MR, 1987, Isr J Med Sci, 23, 174
  2. Sloas MM, 1992, Pediatr Infect Dis J, 11, 662
  3. 1997, MMWR Morb Mortal Wkly Rep, 46, 1
  4. 1999, MMWR Morb Mortal Wkly Rep, 48, 656

Cited by

See all 888

Metadata

Authors
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., Jorgensen, J. H., & Schuchat, A.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Emory University (US)
  • Connecticut Department of Public Health (US)
  • Johns Hopkins University (US)
  • Minnesota Department of Health (US)
  • University of California, Berkeley (US)
  • Vanderbilt University (US)
  • Oregon Department of Human Services (US)
  • The University of Texas at San Antonio Health Science Center (US)
Venue
New England Journal of Medicine
Published
2000-12-28
Volume
343
Issue
26
Pages
1917-1924
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2115071132
Cited by
888
References
41
Citations by year
2026: 5 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 13 · 2020: 7 · 2019: 12 · 2018: 10 · 2017: 12 · 2016: 13 · 2015: 16 · 2014: 35 · 2013: 31 · 2012: 24
FWCI
67.95
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Centers for Disease Control and Prevention
Topics
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords
Streptococcus pneumoniae, multidrug resistance, penicillin resistance, invasive pneumococcal disease, antimicrobial resistance trends, serotypes, 7-valent conjugate vaccine, 23-valent pneumococcal polysaccharide vaccine, cefotaxime resistance, meropenem resistance, erythromycin resistance, trimethoprim-sulfamethoxazole resistance
MeSH terms
Adolescent, Adult, Aged, Child, Child, Preschool, Humans, Microbial Sensitivity Tests, Middle Aged, Penicillin Resistance, Pneumococcal Infections, Population Surveillance, Serotyping, Streptococcus pneumoniae, United States, Prevalence, Drug Resistance, Multiple

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States. https://app.cochat.ai/papers/10.1056/nejm200012283432603
The paper
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., Jorgensen, J. H., & Schuchat, A. (2000). Increasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States. New England Journal of Medicine. https://doi.org/10.1056/nejm200012283432603

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.